Circulatory and prostatic tissue lipidomic profiles shifts after high-dose atorvastatin use in men with prostate cancer

Prostate cancer patients using cholesterol-lowering statins have 30% lower risk of prostate cancer death compared to non-users. The effect is attributed to the inhibition of the mevalonate pathway in prostate cancer cells. Moreover, statin use causes lipoprotein metabolism changes in the serum. Stat...

Descripción completa

Detalles Bibliográficos
Autores principales: Raittinen, Paavo, Niemistö, Kati, Pennanen, Erika, Syvälä, Heimo, Auriola, Seppo, Riikonen, Jarno, Lehtimäki, Terho, Ilmonen, Pauliina, Murtola, Teemu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374714/
https://www.ncbi.nlm.nih.gov/pubmed/32694638
http://dx.doi.org/10.1038/s41598-020-68868-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374714/
https://www.ncbi.nlm.nih.gov/pubmed/32694638
http://dx.doi.org/10.1038/s41598-020-68868-5

Ejemplares similares